Medicinal Mushroom Used in Korea as Cancer Therapy Adjunct
There's a new star on the medicinal mushroom sky. It goes by Phellinus linteus in Latin. The little known English common name is Black Hoof Fungus. It's far more common, even in America, to hear it referred to by its Japanese name as Mesima.
Common to southern United States and Southeast Asia, Phellinus linteus is a polypore on hardwood trees such as poplar, oak and mulberry. [1]
Most medicinal mushroom species used today in America came to us via China or Japan. Phellinus linteus is a break from this trend, as it first became popular in Korea where it's commonly used to complement traditional cancer treatment.
From there, the fame of Phellinus linteus has spread across the globe. Doctors all over the world now use it as an immune enhancer [2-11], particularly to prevent cancer metastasis. [5,10,12-17] In addition to Korea, Phellinus linteus is today also increasingly popular in the U.S., Japan, and the Middle East from Turkey to Israel.
It may have all began when a 1996 Korean study reported that Phellinus linteus extract exhibited a broader range of immune enhancing and anti-cancer properties than the extracts from other species of medicinal mushrooms. [4]
Years later, American world-renown mycologist Paul Stamets helped deepen our understanding of Phellinus linteus when he published a comparative analysis with the most common medicinal mushroom species: Agaricus blazei, Lion's Mane, Chaga, Reishi, Maitake and Cordyceps. [18]
In this study, Phellinus linteus turned out to have the most powerful effect on enhancing the activity of macrophages, a type of white blood cell that's an important part of the immune system. Macrophage activity was increased 5,700% by the Phellinus linteus extract. The dose used was equivalent to 3,750 mg for an average (165 lbs) adult. [18]
It should be noted that macrophages may promote cancer growth as well as fight cancer. The research that has been published about Phellinus linteus extract indicates that it enhances the anti-cancer properties of macrophages. [8,14,19,20]
Three additional papers have been published with reports of patients using Phellinus linteus extract and experiencing "spontaneous" regression:
1. A 2004 paper out of Japan reported "a hormone refractory prostate cancer patient with rapidly progressive bone metastasis who showed dramatic response to intake of an extract from the mushroom, Phellinus linteus." [15]
2. Next out was a Korean article published in 2005, which reported on a patient who "ingested mushroom called Phellinus linteus for one and a half years" before exhibiting "spontaneous regression" of liver cancer and skull metastasis. [17]
3. Finally, an article published 2006 in the Japanese journal Radiation Medicine told of a "patient with hepatocellular carcinoma with multiple lung metastases in whom malignancy spontaneously regressed after taking Phellinus linteus Mycelium." The 79-year old patient reportedly "took extract from Phellinus linteus Mycelium for one month, and 6 months later the tumors appeared to be in complete regression." [16]
Note: This article is not intended to treat, cure or diagnose any disease. It is intended for informational purposes only. Phellinus linteus is not approved by the FDA. Never use any herb or mushroom for medicinal purposes without first consulting a licensed medical professional.
Common to southern United States and Southeast Asia, Phellinus linteus is a polypore on hardwood trees such as poplar, oak and mulberry. [1]
Most medicinal mushroom species used today in America came to us via China or Japan. Phellinus linteus is a break from this trend, as it first became popular in Korea where it's commonly used to complement traditional cancer treatment.
From there, the fame of Phellinus linteus has spread across the globe. Doctors all over the world now use it as an immune enhancer [2-11], particularly to prevent cancer metastasis. [5,10,12-17] In addition to Korea, Phellinus linteus is today also increasingly popular in the U.S., Japan, and the Middle East from Turkey to Israel.
It may have all began when a 1996 Korean study reported that Phellinus linteus extract exhibited a broader range of immune enhancing and anti-cancer properties than the extracts from other species of medicinal mushrooms. [4]
Years later, American world-renown mycologist Paul Stamets helped deepen our understanding of Phellinus linteus when he published a comparative analysis with the most common medicinal mushroom species: Agaricus blazei, Lion's Mane, Chaga, Reishi, Maitake and Cordyceps. [18]
In this study, Phellinus linteus turned out to have the most powerful effect on enhancing the activity of macrophages, a type of white blood cell that's an important part of the immune system. Macrophage activity was increased 5,700% by the Phellinus linteus extract. The dose used was equivalent to 3,750 mg for an average (165 lbs) adult. [18]
It should be noted that macrophages may promote cancer growth as well as fight cancer. The research that has been published about Phellinus linteus extract indicates that it enhances the anti-cancer properties of macrophages. [8,14,19,20]
Three additional papers have been published with reports of patients using Phellinus linteus extract and experiencing "spontaneous" regression:
1. A 2004 paper out of Japan reported "a hormone refractory prostate cancer patient with rapidly progressive bone metastasis who showed dramatic response to intake of an extract from the mushroom, Phellinus linteus." [15]
2. Next out was a Korean article published in 2005, which reported on a patient who "ingested mushroom called Phellinus linteus for one and a half years" before exhibiting "spontaneous regression" of liver cancer and skull metastasis. [17]
3. Finally, an article published 2006 in the Japanese journal Radiation Medicine told of a "patient with hepatocellular carcinoma with multiple lung metastases in whom malignancy spontaneously regressed after taking Phellinus linteus Mycelium." The 79-year old patient reportedly "took extract from Phellinus linteus Mycelium for one month, and 6 months later the tumors appeared to be in complete regression." [16]
Note: This article is not intended to treat, cure or diagnose any disease. It is intended for informational purposes only. Phellinus linteus is not approved by the FDA. Never use any herb or mushroom for medicinal purposes without first consulting a licensed medical professional.
About the Author:
Dr. Markho Rafael currently specializes in research on medicinal mushrooms, having worked with natural health since the mid-90's. He partners with Cordyceps Reishi Extract, LLC, a business offering premium quality medicinal mushroom products including Phellinus linteus extract. For article references, go the Phellinus linteus reference page.
0 comments:
Post a Comment